Managing Expectations of Prolonged Warm Ischemia Time: A Calculator to Predict Donation After Circulatory Death Donor Progression to Circulatory Death Within 30 Min
Yanik J. Bababekov, Carlos Goncalves, Anna H. Ha, Tiffany E. Maksimuk, John S. Malamon, Arthur Yule, David Y. Chen, Jordan R. H. Hoffman, Jesse D. Schold, Elizabeth A. Pomfret, Bruce Kaplan, James J. Pomposelli
{"title":"Managing Expectations of Prolonged Warm Ischemia Time: A Calculator to Predict Donation After Circulatory Death Donor Progression to Circulatory Death Within 30 Min","authors":"Yanik J. Bababekov, Carlos Goncalves, Anna H. Ha, Tiffany E. Maksimuk, John S. Malamon, Arthur Yule, David Y. Chen, Jordan R. H. Hoffman, Jesse D. Schold, Elizabeth A. Pomfret, Bruce Kaplan, James J. Pomposelli","doi":"10.1111/ctr.70336","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Transplant teams may be better prepared to entertain DCD offers with a priori prediction of prolonged warm ischemia time (WIT) and deploy perfusion strategies (PS) to mitigate the risk of WIT.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>All potential adult Maastricht-III DCDs in one Organ Procurement Organization from January 2016 to July 2024 were reviewed. Data were obtained from UNOS DonorNet. Cases with missing variables were excluded. The most recent clinical values prior to withdrawal of life support treatment (WLST) were utilized. Logistic regression assessed the likelihood of DCD progression within 30 min after WLST.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>From a total of 748 potential DCDs, 350 were assessed after exclusion criteria. One hundred and seventy-one (49%) progressed within 30 min. Forty percent (<i>n</i> = 140) of the sample was used for training and 60% (<i>n</i> = 160) for validation. Potassium (OR: 3.01; 95% CI: [1.39, 6.5], <i>p</i> = 0.005), sodium (OR: 1.23; 95% CI: [1.01, 1.50], <i>p</i> = 0.036); body mass index (OR: 1.68; 95% CI: [1.39, 2.03], <i>p</i> = 0.0001) and heart rate (OR: 1.54; 95% CI: [1.24, 1.92], <i>p</i> = 0.0001) positively correlated with progression. Age (OR: 0.71; 95% CI: [0.58, 0.86], <i>p</i> = 0.0006); presence of pupillary reflexes (OR: 0.81; 95% CI:[0.68, 0.92], <i>p</i> = 0.007); presence of corneal reflexes (OR: 0.27; 95% CI: [0.22, 0.34], <i>p</i> = 0.001); and presence of overbreathing the ventilator (OR: 0.39; 95% CI: [0.32, 0.48], <i>p</i> = 0.001) negatively correlated with progression. Discrimination was excellent (NPV 89%; PPV 88%).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>DonorNet variables predict progression to circulatory death within 30 min. If there is an indication that a DCD will not progress within a 30-min threshold, then early discussion of PS may decrease the risk of a dry run.</p>\n </section>\n </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"39 10","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ctr.70336","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Transplant teams may be better prepared to entertain DCD offers with a priori prediction of prolonged warm ischemia time (WIT) and deploy perfusion strategies (PS) to mitigate the risk of WIT.
Methods
All potential adult Maastricht-III DCDs in one Organ Procurement Organization from January 2016 to July 2024 were reviewed. Data were obtained from UNOS DonorNet. Cases with missing variables were excluded. The most recent clinical values prior to withdrawal of life support treatment (WLST) were utilized. Logistic regression assessed the likelihood of DCD progression within 30 min after WLST.
Results
From a total of 748 potential DCDs, 350 were assessed after exclusion criteria. One hundred and seventy-one (49%) progressed within 30 min. Forty percent (n = 140) of the sample was used for training and 60% (n = 160) for validation. Potassium (OR: 3.01; 95% CI: [1.39, 6.5], p = 0.005), sodium (OR: 1.23; 95% CI: [1.01, 1.50], p = 0.036); body mass index (OR: 1.68; 95% CI: [1.39, 2.03], p = 0.0001) and heart rate (OR: 1.54; 95% CI: [1.24, 1.92], p = 0.0001) positively correlated with progression. Age (OR: 0.71; 95% CI: [0.58, 0.86], p = 0.0006); presence of pupillary reflexes (OR: 0.81; 95% CI:[0.68, 0.92], p = 0.007); presence of corneal reflexes (OR: 0.27; 95% CI: [0.22, 0.34], p = 0.001); and presence of overbreathing the ventilator (OR: 0.39; 95% CI: [0.32, 0.48], p = 0.001) negatively correlated with progression. Discrimination was excellent (NPV 89%; PPV 88%).
Conclusions
DonorNet variables predict progression to circulatory death within 30 min. If there is an indication that a DCD will not progress within a 30-min threshold, then early discussion of PS may decrease the risk of a dry run.
期刊介绍:
Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored.
Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include:
Immunology and immunosuppression;
Patient preparation;
Social, ethical, and psychological issues;
Complications, short- and long-term results;
Artificial organs;
Donation and preservation of organ and tissue;
Translational studies;
Advances in tissue typing;
Updates on transplant pathology;.
Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries.
Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.